Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Christina Lamers, Daniel Flesch, Manfred Schubert-Zsilavecz & Daniel Merk. (2013) Novel prostaglandin receptor modulators: a patent review (2002 – 2012) – part I: non-EP receptor modulators. Expert Opinion on Therapeutic Patents 23:1, pages 47-77.
Read now
Read now
Peter Norman. (2012) Evaluation of WO2012078210 – development process for the preparation of a DP2 receptor antagonist; Ironwood's first development DP2 antagonist. Expert Opinion on Therapeutic Patents 22:10, pages 1257-1261.
Read now
Read now
Peter Norman. (2011) A novel DP2 receptor antagonist (AM-461): a patent evaluation of WO2011085033. Expert Opinion on Therapeutic Patents 21:12, pages 1931-1936.
Read now
Read now
Articles from other publishers (46)
Hamed Aissaoui, Martin Holdener, Carmela Gnerre, Kerstin Niggemann, Stefan Reber, Sylvia Richard, Romain Siegrist & Christoph Boss. (2023) Design, Synthesis, and Optimization of Indole Acetic Acid Derivatives as Potent and Selective CRTH2 Receptor Antagonists: Discovery of ACT‐774312. ChemMedChem 18:10.
Crossref
Crossref
Francesco Nucera, Federica Lo Bello, Sj S. Shen, Paolo Ruggeri, Irene Coppolino, Antonino Di Stefano, Cristiana Stellato, Vincenzo Casolaro, Phil M. Hansbro, Ian M. Adcock & Gaetano Caramori. (2021) Role of Atypical Chemokines and Chemokine Receptors Pathways in the Pathogenesis of COPD. Current Medicinal Chemistry 28:13, pages 2577-2653.
Crossref
Crossref
Clinton B. Mathias. 2020. Pharmacology of Immunotherapeutic Drugs. Pharmacology of Immunotherapeutic Drugs
141
174
.
Huihui Ti, Yang Zhou, Xue Liang, Runfeng Li, Ke Ding & Xin Zhao. (2019) Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs). Journal of Medicinal Chemistry 62:13, pages 5944-5978.
Crossref
Crossref
Xianhai Huang, Jason Brubaker, Wei Zhou, Purakkattle J. Biju, Li Xiao, Ning Shao, Ying Huang, Li Dong, Zhidan Liu, Rema Bitar, Alexei Buevich, Joon Jung, Scott L. Peterson, John W. Butcher, Joshua Close, Michelle Martinez, Rachel N. MacCoss, Hongjun Zhang, Scott Crawford, Kevin D. McCormick, Robert Aslanian, Ravi Nargund, Craig Correll, Francois Gervais, Hongchen Qiu, Xiaoxin Yang, Charles Garlisi, Diane Rindgen, Kevin M. Maloney, Phieng Siliphaivanh & Anandan Palani. (2018) Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of Asthma. ACS Medicinal Chemistry Letters 9:7, pages 679-684.
Crossref
Crossref
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery
15
58
.
Patrick M. Brunner, Emma Guttman-Yassky & Donald Y.M. Leung. (2017) The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. Journal of Allergy and Clinical Immunology 139:4, pages S65-S76.
Crossref
Crossref
Roopesh Singh Gangwar, Nadine Landolina, Ludovica Arpinati & Francesca Levi-Schaffer. (2017) Mast cell and eosinophil surface receptors as targets for anti-allergic therapy. Pharmacology & Therapeutics 170, pages 37-63.
Crossref
Crossref
Veit J. Erpenbeck, Eva Vets, Lien Gheyle, Wande Osuntokun, Michael Larbig, Srikanth Neelakantham, David Sandham, Gerald Dubois, Walid Elbast, Paul Goldsmith & Markus Weiss. (2016) Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo‐Controlled Studies in Healthy Volunteers. Clinical Pharmacology in Drug Development 5:4, pages 306-313.
Crossref
Crossref
Christel A.S. Bergström, William N. Charman & Christopher J.H. Porter. (2016) Computational prediction of formulation strategies for beyond-rule-of-5 compounds. Advanced Drug Delivery Reviews 101, pages 6-21.
Crossref
Crossref
Maria Antonia Buil, Marta Calbet, Marcos Castillo, Jordi Castro, Cristina Esteve, Manel Ferrer, Pilar Forns, Jacob González, Sara López, Richard S. Roberts, Sara Sevilla, Bernat Vidal, Laura Vidal & Pere Vilaseca. (2016) Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of sulphone-based CRTh2 antagonists. European Journal of Medicinal Chemistry 113, pages 102-133.
Crossref
Crossref
Sathya Babu, Santhosh Kumar Nagarajan, Sung Haeng Lee & Thirumurthy Madhavan. (2016) Structural characterization of human CRTh2: a combined homology modeling, molecular docking and 3D-QSAR-based in silico approach. Medicinal Chemistry Research 25:4, pages 653-671.
Crossref
Crossref
Sathya Babu. (2015) Pharmacophore-Based Comparative Molecular Similarity Indices Analysis of CRTh2 Antagonists. Journal of the Chosun Natural Science 8:4, pages 273-284.
Crossref
Crossref
Sathya Babu, Seema A. Kulkarni, Honglae Sohn & Thirumurthy Madhavan. (2015) Identification of leads through in silico approaches utilizing benzylthio-1H-benzo[d]imidazol-1-yl acetic acid derivatives: A potent CRTh2 antagonist. Journal of Molecular Structure 1102, pages 25-41.
Crossref
Crossref
Sathya Babu & Thirumurthy Madhavan. (2015) Pharmacophore Based Comparative Molecular Field Analysis of CRTh2 Antagonists. Journal of the Chosun Natural Science 8:2, pages 89-98.
Crossref
Crossref
Daniel S. Strasser, Hervé Farine, Martin Holdener, Jochen Zisowsky, René Roscher, Julie Hoerner, Martine Gehin, Patricia N. Sidharta, Jasper Dingemanse & Peter M.A. Groenen. (2015) Development of a decision-making biomarker for CRTH2 antagonism in clinical studies. European Journal of Molecular & Clinical Medicine 2:4-5, pages 118.
Crossref
Crossref
Sathya Babu, Honglae Sohn & Thirumurthy Madhavan. (2015) Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach. Computational Biology and Chemistry 56, pages 109-121.
Crossref
Crossref
Sathya Babu & Thirumurthy Madhavan. (2015) Ligand Based HQSAR Analysis of CRTh2 Antagonists. Journal of the Chosun Natural Science 8:1, pages 1-12.
Crossref
Crossref
Patricia N. Sidharta, Zuzana Diamant & Jasper Dingemanse. (2014) Single- and multiple-dose tolerability and pharmacokinetics of the CRTH2 antagonist setipiprant in healthy male subjects. Fundamental & Clinical Pharmacology 28:6, pages 690-699.
Crossref
Crossref
Juan Antonio Alonso, Miriam Andrés, Mónica Bravo, Maria Antonia Buil, Marta Calbet, Jordi Castro, Paul R. Eastwood, Peter Eichhorn, Cristina Esteve, Elena Gómez, Jacob González, Marta Mir, Silvia Petit, Richard S. Roberts, Bernat Vidal, Laura Vidal, Pere Vilaseca & Miriam Zanuy. (2014) Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists I. Bioorganic & Medicinal Chemistry Letters 24:21, pages 5118-5122.
Crossref
Crossref
Juan Antonio Alonso, Miriam Andrés, Mónica Bravo, Marta Calbet, Paul R. Eastwood, Peter Eichhorn, Cristina Esteve, Manel Ferrer, Elena Gómez, Jacob González, Marta Mir, Imma Moreno, Silvia Petit, Richard S. Roberts, Sara Sevilla, Bernat Vidal, Laura Vidal, Pere Vilaseca & Miriam Zanuy. (2014) Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists II: Lead optimization. Bioorganic & Medicinal Chemistry Letters 24:21, pages 5123-5126.
Crossref
Crossref
Juan Antonio Alonso, Miriam Andrés, Mónica Bravo, Maria Antonia Buil, Marta Calbet, Jordi Castro, Paul R. Eastwood, Cristina Esteve, Manel Ferrer, Pilar Forns, Elena Gómez, Jacob González, Estrella Lozoya, Marta Mir, Imma Moreno, Silvia Petit, Richard S. Roberts, Sara Sevilla, Bernat Vidal, Laura Vidal & Pere Vilaseca. (2014) Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists III: The role of a hydrogen-bond acceptor in long receptor residence times. Bioorganic & Medicinal Chemistry Letters 24:21, pages 5127-5133.
Crossref
Crossref
Miriam Andrés, Maria Antonia Buil, Marta Calbet, Oscar Casado, Jordi Castro, Paul R. Eastwood, Peter Eichhorn, Manel Ferrer, Pilar Forns, Imma Moreno, Silvia Petit & Richard S. Roberts. (2014) Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of pyrrolopiperidinone acetic acids as CRTh2 antagonists. Bioorganic & Medicinal Chemistry Letters 24:21, pages 5111-5117.
Crossref
Crossref
Haixia Liu, Mingrui Zheng, Jianou Qiao, Yajie Dang, Pengyu Zhang & Xianqiao Jin. (2014)
Role of prostaglandin D
2
/CRTH2 pathway on asthma exacerbation induced by
Aspergillus fumigatus
. Immunology 142:1, pages 78-88.
Crossref
Crossref
Dong Xiao, Xiaohong Zhu, Younong Yu, Ning Shao, Jie Wu, Kevin D. McCormick, Pawan Dhondi, Jun Qin, Robert Mazzola, Haiqun Tang, Ashwin Rao, Phieng Siliphaivanh, Hongchen Qiu, Xiaoxin Yang, Maria Rivelli, Charles G. Garlisi, Steve Eckel, Gitali Mukhopadhyay, Craig Correll, Diane Rindgen, Robert Aslanian & Anandan Palani. (2014) Quality by design (QbD) of amide isosteres: 5,5-Disubstituted isoxazolines as potent CRTh2 antagonists with favorable pharmacokinetic and drug-like properties. Bioorganic & Medicinal Chemistry Letters 24:6, pages 1615-1620.
Crossref
Crossref
Miriam Andrés, Mónica Bravo, Maria Antonia Buil, Marta Calbet, Marcos Castillo, Jordi Castro, Peter Eichhorn, Manel Ferrer, Martin D. Lehner, Imma Moreno, Richard S. Roberts & Sara Sevilla. (2014) 2-(1H-Pyrazol-1-yl)acetic acids as chemoattractant receptor-homologous molecule expressed on Th2 lymphocytes (CRTh2) antagonists. European Journal of Medicinal Chemistry 71, pages 168-184.
Crossref
Crossref
Noel Snell, Martyn Foster & Jørgen Vestbo. (2013) Efficacy and safety of AZD1981, a CRTH2 receptor antagonist, in patients with moderate to severe COPD. Respiratory Medicine 107:11, pages 1722-1730.
Crossref
Crossref
Miriam Andrés, Mónica Bravo, Maria Antonia Buil, Marta Calbet, Jordi Castro, Teresa Domènech, Peter Eichhorn, Manel Ferrer, Elena Gómez, Martin D. Lehner, Imma Moreno, Richard S. Roberts & Sara Sevilla. (2013) 2-(1H-Pyrazol-4-yl)acetic acids as CRTh2 antagonists. Bioorganic & Medicinal Chemistry Letters 23:11, pages 3349-3353.
Crossref
Crossref
JA Schmidt, FM Bell, E Akam, C Marshall, IA Dainty, A Heinemann, IG Dougall, RV Bonnert & CA Sargent. (2013)
Biochemical and pharmacological characterization of AZD1981, an orally available selective DP
2
antagonist in clinical development for asthma
. British Journal of Pharmacology 168:7, pages 1626-1638.
Crossref
Crossref
Thomas Werfel. 2013. Fortschritte der praktischen Dermatologie und Venerologie 2012. Fortschritte der praktischen Dermatologie und Venerologie 2012
301
308
.
Mark Ballow, Cezmi A. Akdis, Thomas B. Casale, Andrew J. Wardlaw, Sally E. Wenzel, Zuhair Ballas & Jan Lötvall. (2012) Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology. Journal of Allergy and Clinical Immunology 130:2, pages 311-324.
Crossref
Crossref
L. NATHAN TUMEY. 2012. Anti-Inflammatory Drug Discovery. Anti-Inflammatory Drug Discovery
104
134
.
Neelu Kaila, Adrian Huang, Alessandro Moretto, Bruce Follows, Kristin Janz, Michael Lowe, Jennifer Thomason, Tarek S. Mansour, Cedric Hubeau, Karen Page, Paul Morgan, Susan Fish, Xin Xu, Cara Williams & Eddine Saiah. (2012) Diazine Indole Acetic Acids as Potent, Selective, and Orally Bioavailable Antagonists of Chemoattractant Receptor Homologous Molecule Expressed on Th2 Cells (CRTH2) for the Treatment of Allergic Inflammatory Diseases. Journal of Medicinal Chemistry 55:11, pages 5088-5109.
Crossref
Crossref
M. Abid Masood, Mark Gardner, Kevin Dack, David Winpenny & Graham Lunn. (2012) Use of libraries to access new chemical space: Applications to CRTH2. Bioorganic & Medicinal Chemistry Letters 22:11, pages 3682-3687.
Crossref
Crossref
Roy PettipherMark Whittaker. (2012) Update on the Development of Antagonists of Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2). From Lead Optimization to Clinical Proof-of-Concept in Asthma and Allergic Rhinitis. Journal of Medicinal Chemistry 55:7, pages 2915-2931.
Crossref
Crossref
Roy Pettipher, Shân L. Vinall, Luzheng Xue, Graham Speight, Elizabeth R. Townsend, Lucien Gazi, Cliff J. Whelan, Richard E. Armer, Mark A. Payton & Michael G. Hunter. (2012) Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils. Journal of Pharmacology and Experimental Therapeutics 340:2, pages 473-482.
Crossref
Crossref
Miriam Sedej, Ralf Schröder, Kathrin Bell, Wolfgang Platzer, Anela Vukoja, Evi Kostenis, Akos Heinemann & Maria Waldhoer. (2012) D-type prostanoid receptor enhances the signaling of chemoattractant receptor–homologous molecule expressed on TH2 cells. Journal of Allergy and Clinical Immunology 129:2, pages 492-500.e9.
Crossref
Crossref
Jean-Pierre Lavoie, Josiane Lefebvre-Lavoie, Mathilde Leclere, Anouk Lavoie-Lamoureux, Annie Chamberland, Catherine Laprise & Jacques Lussier. (2012) Profiling of Differentially Expressed Genes Using Suppression Subtractive Hybridization in an Equine Model of Chronic Asthma. PLoS ONE 7:1, pages e29440.
Crossref
Crossref
Stefano Crosignani, Catherine Jorand-Lebrun, Gordon Campbell, Adeline Prêtre, Tania Grippi-Vallotton, Anna Quattropani, Gwenaelle Bouscary-Desforges, Agnes Bombrun, Marc Missotten, Yves Humbert, Christèle Frémaux, Mikaël Pâquet, Kamel El Harkani, Charles G. Bradshaw, Christophe Cleva, Nada Abla, Hamina Daff, Olivier Schott, Pierre-André Pittet, Jean-François Arrighi, Marilène Gaudet & Zoë Johnson. (2011) Discovery of a Novel Series of CRTH2 (DP2) Receptor Antagonists Devoid of Carboxylic Acids. ACS Medicinal Chemistry Letters 2:12, pages 938-942.
Crossref
Crossref
Laurent Misery. (2010) Atopic Dermatitis and the Nervous System. Clinical Reviews in Allergy & Immunology 41:3, pages 259-266.
Crossref
Crossref
Sanjay N. Mandhane, Jigar H. Shah & Rajamannar Thennati. (2011) Allergic rhinitis: An update on disease, present treatments and future prospects. International Immunopharmacology 11:11, pages 1646-1662.
Crossref
Crossref
Jill M. Scott, Christopher Baccei, Gretchen Bain, Alex Broadhead, Jilly F. Evans, Patrick Fagan, John H. Hutchinson, Christopher King, Daniel S. Lorrain, Catherine Lee, Peppi Prasit, Pat Prodanovich, Angelina Santini & Brian A. Stearns. (2011) Discovery and optimization of a biphenylacetic acid series of prostaglandin D2 receptor DP2 antagonists with efficacy in a murine model of allergic rhinitis. Bioorganic & Medicinal Chemistry Letters 21:21, pages 6608-6612.
Crossref
Crossref
Stefano Crosignani, Adeline Prêtre, Catherine Jorand-Lebrun, Gaële Fraboulet, Jeyaprakashnarayanan Seenisamy, John Kallikat Augustine, Marc Missotten, Yves Humbert, Christophe Cleva, Nada Abla, Hamina Daff, Olivier Schott, Manfred Schneider, Fabienne Burgat-Charvillon, Delphine Rivron, Ingrid Hamernig, Jean-François Arrighi, Marilène Gaudet, Simone C. Zimmerli, Pierre Juillard & Zoe Johnson. (2011) Discovery of Potent, Selective, and Orally Bioavailable Alkynylphenoxyacetic Acid CRTH2 (DP2) Receptor Antagonists for the Treatment of Allergic Inflammatory Diseases. Journal of Medicinal Chemistry 54:20, pages 7299-7317.
Crossref
Crossref
Stefano Crosignani, Catherine Jorand-Lebrun, Patrick Page, Gordon Campbell, Véronique Colovray, Marc Missotten, Yves Humbert, Christophe Cleva, Jean-François Arrighi, Marilène Gaudet, Zoe Johnson, Pamela Ferro & André Chollet. (2011) Optimization of the Central Core of Indolinone–Acetic Acid-Based CRTH2 (DP2) Receptor Antagonists. ACS Medicinal Chemistry Letters 2:8, pages 644-649.
Crossref
Crossref
Jiwen (Jim) Liu, Alan C. Cheng, H. Lucy Tang & Julio C. Medina. (2011) Benzodiazepinone Derivatives as CRTH2 Antagonists. ACS Medicinal Chemistry Letters 2:7, pages 515-518.
Crossref
Crossref
Laurence E. Burgess. 2011.
119
134
.